One Capital Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$706K Buy
5,067
+50
+1% +$7K 0.02% 344
2025
Q4
$616K Sell
5,017
-73
-1% -$8.87K 0.02% 362
2025
Q3
$565K Buy
5,090
+12
+0.2% +$1.36K 0.02% 355
2025
Q2
$563K Buy
5,078
+98
+2% +$10.4K 0.02% 351
2025
Q1
$558K Sell
4,980
-826
-14% -$85.2K 0.02% 281
2024
Q4
$536K Buy
5,806
+6
+0.1% +$540 0.02% 267
2024
Q3
$486K Hold
5,800
0.02% 283
2024
Q2
$398K Buy
5,800
+1,560
+37% +$104K 0.01% 304
2024
Q1
$311K Sell
4,240
-1,601
-27% -$123K 0.01% 249
2023
Q4
$473K Sell
5,841
-1,693
-22% -$132K 0.02% 217
2023
Q3
$565K Buy
+7,534
New +$579K 0.03% 195
2017
Q4
Sell
-33,274
Closed -$2.7M 153
2017
Q3
$2.7M Buy
33,274
+4,621
+16% +$353K 0.56% 56
2017
Q2
$2.03M Buy
28,653
+2,794
+11% +$186K 0.6% 66
2017
Q1
$1.76M Buy
25,859
+1,524
+6% +$107K 0.55% 67
2016
Q4
$1.74M Sell
24,335
-3
-0% -$223 0.55% 65
2016
Q3
$1.93M Buy
+24,338
New +$1.98M 0.63% 57

Other funds holding GILD

One Capital Management's GILD Position: Q1 2026 in Review

One Capital Management increased its Gilead Sciences (GILD) stake by 1% in Q1 2026, buying an estimated $7K and bringing the position to 5,067 shares worth $706K. The position accounts for 0.02% of the portfolio, ranked #344.

One Capital Management first reported a position in GILD in Q3 2016 and has held it in 16 quarters since. The position peaked at $2.7M in Q3 2017. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • One Capital Management held 5,067 shares of Gilead Sciences worth $706K as of Q1 2026.
  • One Capital Management bought 50 Gilead Sciences shares in Q1 2026, an estimated $7K.
  • Gilead Sciences made up 0.02% of One Capital Management's portfolio in Q1 2026, its #344 holding.
  • One Capital Management first reported a position in Gilead Sciences in Q3 2016 and has held it in 16 quarters since.
  • One Capital Management's Gilead Sciences position peaked at $2.7M in Q3 2017.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.